4840480

CD8a Rat anti-Mouse, BB515, Clone: 53-6.7, BD

Rat Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

CD8a

Concentration

0.2mg/mL

Classification

Monoclonal

Host Species

Rat

Target Species

Mouse

Isotype

IgG2a κ

Purification Method

Affinity Purified

Description

Cd8a; CD8 alpha chain; Ly-2; Lyt2; Lyt-2; Ly-35; Ly-B

Clone

53-6.7

Applications

Flow Cytometry

Conjugate

Brilliant Blue 515 (BB515)

Regulatory Status

RUO

Immunogen

Mouse Spleen Cells or Thymocyte Membranes

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Related Products

Img

Fischer Scientific

4840407

Rat Monoclonal Antibody...

Img

Fischer Scientific

4840364

Rat Monoclonal Antibody...

Img

Fischer Scientific

4840421

Rat Monoclonal Antibody...

Img

Fischer Scientific

4840408

Mouse Monoclonal Antibody...

Img

Fischer Scientific

4840419

Mouse Monoclonal Antibody...

Img

Fischer Scientific

4840447

Mouse Monoclonal Antibody...

Img

Fischer Scientific

4840433

Mouse Monoclonal Antibody...

Img

Fischer Scientific

4840461

Mouse Monoclonal Antibody...

Description

  • The 53-6.7 antibody monoclonal antibody specifically binds to the 38 kDa α and 34 kDa α chains of the CD8 differentiation antigen (Ly-2 or Lyt-2) of all mouse strains tested
  • The CD8 α and α chains (CD8a) form heterodimers with the CD8 β chain (CD8b, Ly-3, or Lyt-3) on the surface of most thymocytes
  • A subpopulation of mature T lymphocytes (i.e., MHC class I-restricted T cells, including most T suppressor/cytotoxic cells) expresses almost exclusively the CD8 αβ heterodimer (the αα chains arise from alternatively spliced messengers of a single CD8a gene
  • The longer α form associates with p56 [lck] via a CXCP motif in its cytoplasmic domain, which it shares with CD4, but not with CD8b
  • The truncated α chain is unable to associate with p56 [lck], and it may function to attenuate the CD8-mediated costimulatory signal during intrathymic T-cell maturation
  • In vivo and in vitro treatment with 53-6.7 mAb has reportedly been effective at depleting CD8+ peripheral T lymphocytes
  • The 53-6.7 antibody has also been reported to cross-reaact with CD8 α- and α-like polypeptides on subsets of thymic and peripheral lymphocytes in the Egyptian toad, Bufo regularis .